Neuroprotective effect of Valeriana wallichii rhizome extract against the neurotoxin MPTP in C57BL/6 mice

NeuroToxicology

Volumn 51, Issue , 2015, Pages 172-183

  Sridharan, Subhashree ^a   Mohankumar, Kumaravel ^a   Jeepipalli, Syam Praveen Kumar ^a   Sankaramourthy, Divya ^b   Ronsard, Larance ^c   Subramanian, Kavimani ^b   Thamilarasan, Manivasagam ^d   Raja, Kumar ^e   Chandra, Varshney Khub ^e   Sadras, Sudha Rani ^a  

^a PONDICHERRY UNIVERSITY   (India)

^b Research Institute of Health sciences   (India)

^c NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^d ANNAMALAI UNIVERSITY   (India)

^e Rajiv Gandhi Institute of Veterinary Education and Research   (India)

Author keywords

Antioxidants; Dopamine; MPTP; Parkinson's disease; Tyrosine hydroxylase; Valeriana wallichii D.C.

Indexed keywords

DOPAMINE; GLIAL FIBRILLARY ACIDIC PROTEIN; NEUROPROTECTIVE AGENT; PLANT EXTRACT; REACTIVE OXYGEN METABOLITE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG; VALERIANA WALLICHII EXTRACT; ANTIOXIDANT; VALERIAN;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL COUNT; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFECT; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MASS FRAGMENTOGRAPHY; MOUSE; NEUROPROTECTION; NONHUMAN; PHYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHIZOME; VALERIANA; VALERIANA WALLICHII; WESTERN BLOTTING; ANIMAL; ASTROCYTE; C57BL MOUSE; CHEMISTRY; CORPUS STRIATUM; DRUG EFFECTS; ENCEPHALITIS; MALE; MESENCEPHALON; METABOLISM; MOTOR ACTIVITY; NERVE CELL; ODOR; PARKINSONIAN DISORDERS; PATHOLOGY; SMELLING;

ANIMALS; ANTIOXIDANTS; ASTROCYTES; CORPUS STRIATUM; DOPAMINE; ENCEPHALITIS; LIPID PEROXIDATION; MALE; MESENCEPHALON; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NEURONS; NEUROPROTECTIVE AGENTS; OLFACTORY PERCEPTION; PARKINSONIAN DISORDERS; PLANT EXTRACTS; REACTIVE OXYGEN SPECIES; RHIZOME; SMELL; TYROSINE 3-MONOOXYGENASE; VALERIAN;

EID: 84946556005     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2015.10.012     Document Type: Article

References (68)

1. Albarracin S.L., Stab B., Casas Z., Sutachan J.J., Samudio I., Gonzalez J., Gonzalo L., Capani F., Morales L., Barreto G.E. Effects of natural antioxidants in neurodegenerative disease. Nutr. Neurosci. 2012, 15:1-9.
2. Anandhan A., Tamilselvam K., Vijayraja D., Ashokkumar N., Rajasankar S., Manivasagam T. Resveratrol attenuates oxidative stress and improves behaviour in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) challenged mice. Ann. Neurosci. 2010, 17:113-119.
3. Antunes M.S., Goes A.T.R., Boeira S.P., Prigol M., Jesse C.R. Protective effect of hesperidin in a model of Parkinson's disease induced by 6-hydroxydopamine in aged mice. Nutrition 2014, (in press). 10.1016/j.nut.2014.03.024.
4. Aoyama K., Watabe M., Nakaki T. Regulation of neuronal glutathione synthesis. J. Pharmacol. Sci. 2008, 108:227-238.
5. Barcia C. Glial-mediated inflammation underlying parkinsonism. Scientifica (Cairo) 2013, 2013:357805.
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
7. Brown R.E., Corey S.C., Moore A.K. Differences in measures of exploration and fear in MHC-congenic C57BL/6J and B6-H-2K mice. Behav. Genet. 1999, 29:263-271.
8. Calabrese V., Scapagnini G., Ravagna A., Fariello R.G., Giuffrida Stella A.M., Abraham N.G. Regional distribution of heme oxygenase, HSP70, and glutathione in brain: relevance for endogenous oxidant/antioxidant balance and stress tolerance. J. Neurosci. Res. 2002, 68:65-75.
9. Carlberg I., Mannervik B. Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J. Biol. Chem. 1975, 250:5475-5480.
10. Carlson C.G., Rutter J., Bledsoe C., Singh R., Hoff H., Bruemmer K., Sesti J., Gatti F., Berge J., McCarthy L. A simple protocol for assessing inter-trial and inter-examiner reliability for two noninvasive measures of limb muscle strength. J. Neurosci. Methods 2010, 186:226-230. 10.1016/j.jneumeth.2009.11.006.
11. Czlonkowska A., Kurkowska-Jastrzebska I., Czlonkowski A. Role of inflammatory factors in neurodegeneration. Neurol. Neurochir. Pol. 2001, 35:13-22.
12. Dawson P.A., Steane S.E., Markovich D. Impaired memory and olfactory performance in NaSi-1 sulphate transporter deficient mice. Behav. Brain Res. 2005, 159:15-20. 10.1016/j.bbr.2004.09.020.
13. de Oliveria D.M., Barreto G., De Andrade D.V., Saraceno E., Aon-Bertolino L., Capani F., Dos Santos El Bachá R., Giraldez L.D. Cytoprotective effect of Valeriana officinalis extract on an in vitro experimental model of Parkinson disease. Neurochem. Res. 2009, 34:215-220. 10.1007/s11064-008-9749-y.
14. Dexter D.T., Carter C.J., Wells F.R., Javoy-Agid F., Agid Y., Lees A., Jenner P., Marsden C.D. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 1989, 52:381-389.
15. Dexter D.T., Holley A.E., Flitter W.D., Slater T.F., Wells F.R., Daniel S.E., Lees A.J., Jenner P., Marsden C.D. Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study. Mov. Disord. 1994, 9:92-97. 10.1002/mds.870090115.
16. Ellman G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 1959, 82:70-77.
17. Fernagut P.O., Diguet E., Labattu B., Tison F. A simple method to measure stride length as an index of nigrostriatal dysfunction in mice. J. Neurosci. Methods 2002, 113:123-130.
18. Goldenberg S.S., De Boni U. Pure population of viable neurons from rabbit dorsal root ganglia, using gradients of Percoll. J. Neurobiol. 1983, 14:195-206.
19. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 1974, 249:7130-7139.
20. Haupt C., Witte O.W., Frahm C. Up-regulation of Connexin43 in the glial scar following photothrombotic ischemic injury. Mol. Cell. Neurosci. 2007, 35:89-99.
21. Hirsch E.C., Hunot S. Neuroinflammation in Parkinson's disease: a target for neuroprotection?. Lancet Neurol. 2009, 8:382-397.
22. Hodge G.K., Butcher L.L. Pars compacta of the substantia nigra modulates motor activity but is not involved importantly in regulating food and water intake. Naunyn. Schmiedebergs Arch. Pharmacol. 1980, 313:51-67.
23. Hornykiewicz O., Kish S.J. Biochemical pathophysiology of Parkinson's disease. Adv. Neurol. 1987, 45:19-34.
24. Hung H.C., Lee E.H. MPTP produces differential oxidative stress and antioxidative responses in the nigrostriatal and mesolimbic dopaminergic pathways. Free Radic. Biol. Med. 1998, 24:76-84.
25. Jezek P., Hlavata L. Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int. J. Biochem. Cell Biol. 2005, 37:2478-2503. 10.1016/j.biocel.2005.05.013.
26. Kalim M.D., Bhattacharyya D., Banerjee A., Chattopadhyay S. Oxidative DNA damage preventive activity and antioxidant potential of plants used in Unani system of medicine. BMC Complement. Altern. Med. 2010, 10:77. 10.1186/1472-6882-10-77.
27. Katoch O., Kaushik S., Kumar M.S., Agrawala P.K., Misra K. Radioprotective property of an aqueous extract from Valeriana wallichii. J. Pharm. Bioallied Sci. 2012, 4:327-332. 10.4103/0975-7406.103272.
28. Kim H.G., Ju M.S., Ha S.K., Lee H., Lee H., Kim S.Y., Oh M.S. Acacetin protects dopaminergic cells against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neuroinflammation in vitro and in vivo. Biol. Pharm. Bull. 2012, 35(8):1287-1294.
29. Koppula S., Kumar H., More S.V., Lim H.W., Hong S.M., Choi D.K. Recent updates in redox regulation and free radical scavenging effects by herbal products in experimental models of Parkinson's disease. Molecules 2012, 17:11391-11420. 10.3390/molecules171011391.
30. Kumar H., Lim H.W., More S.V., Kim B.W., Koppula S., Kim I.S., Choi D.K. The role of free radicals in the aging brain and Parkinson's disease: convergence and parallelism. Int. J. Mol. Sci. 2012, 13:10478-10504. 10.3390/ijms130810478.
31. Kurtenbach S., Wewering S., Hatt H., Neuhaus E.M., Lubbert H. Olfaction in three genetic and two MPTP-induced Parkinson's disease mouse models. PLOS ONE 2013, 8:e77509. 10.1371/journal.pone.0077509.
32. LeBel C.P., Ali S.F., McKee M., Bondy S.C. Organometal-induced increases in oxygen reactive species: the potential of 2',7'-dichlorofluorescin diacetate as an index of neurotoxic damage. Toxicol. Appl. Pharmacol. 1990, 104:17-24.
33. Luna L.G. Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology 1968, McGraw Hill, New York, USA.
34. Marder M., Viola H., Wasowski C., Fernandez S., Medina J.H., Paladini A.C. 6-Methylapigenin and hesperidin: new valeriana flavonoids with activity on the CNS. Pharmacol. Biochem. Behav. 2003, 75:537-545.
35. Martin H.L., Teismann P. Glutathione - a review on its role and significance in Parkinson's disease. FASEB J. 2009, 23:3263-3272.
36. Marzatico F., Café C., Taborelli M., Benzi G. Experimental Parkinson's disease in monkeys: effect of ergot alkaloid derivative on lipid peroxidation in different brain areas. Neurochem. Res. 1993, 18:1101-1106.
37. Miller R.L., James-Kracke M., Sun G.Y., Sun A.Y. Oxidative and inflammatory pathways in Parkinson's disease. Neurochem. Res. 2009, 34:55-65. 10.1007/s11064-008-9656-2.
38. Mogi M., Harada M., Narabayashi H., Inagaki H., Minami M., Nagatsu T. Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease. Neurosci. Lett. 1996, 211:13-16.
39. Mohanasundari M., Srinivasan M.S., Sethupathy S., Sabesan M. Enhanced neuroprotective effect by combination of bromocriptine and Hypericum perforatum extract against MPTP-induced neurotoxicity in mice. J. Neurol. Sci. 2006, 249:140-144. 10.1016/j.jns.2006.06.018.
40. Moon M., Kim H.G., Hwang L., Seo J.H., Kim S., Hwang S., Lee D., Chung H., Oh M.S., Lee K.T., Park S. Neuroprotective effect of ghrelin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease by blocking microglial activation. Neurotox. Res. 2009, 15:332-347.
41. More S.V., Kumar H., Kang S.M., Song S.Y., Lee K., Choi D.K. Advances in neuroprotective ingredients of medicinal herbs by using cellular and animal models of Parkinson's disease. Evid. Based Complement. Alternat. Med. 2013, 2013:957875. 10.1155/2013/957875.
42. Nagatsu T., Mogi M., Ichinose H., Togari A. Changes in cytokines and neurotrophins in Parkinson's disease. J. Neural Transm. 2000, 277-290.
43. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
44. RajaSankar S., Manivasagam T., Sankar V., Prakash S., Muthusamy R., Krishnamurti A., Surendran S. Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson's disease model mouse. J. Ethnopharmacol. 2009, 125:369-373. 10.1016/j.jep.2009.08.003.
45. Rehni A.K., Pantlya H.S., Shri R., Singh M. Effect of chlorophyll and aqueous extracts of Bacopa monniera and Valeriana wallichii on ischaemia and reperfusion-induced cerebral injury in mice. Indian J. Exp. Biol. 2007, 45:764-769.
46. Rodrigues R.W., Gomide V.C., Chadi G. Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6-hydroxydopamine. Int. J. Neurosci. 2001, 109:91-126.
47. Rojas P., Rios C. Increased striatal lipid peroxidation after intracerebroventricular MPP + administration to mice. Pharmacol. Toxicol. 1993, 72:364-368.
48. Rosen G.D., Williams A.G., Capra J.A., Connolly M.T., Cruz B., Lu L., Airey D.C., Kulkarni K., Williams R.W. The Mouse Brain Library @ www.mbl.org. Int. Mouse Genome Conference, vol. 14 2000, 166. www.mbl.org (accessed 4.01.14).
49. Rotruck J.T., Pope A.L., Ganther H.E., Swanson A.B., Hafeman D.G., Hoekstra W.G. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973, 179:588-590.
50. Sangeeta P.S., Mathela C.S., Chopra K. Valeriana wallichii: a phyto-pharmacological review. J. Pharm. Res. 2010, 3:2337-2339.
51. Sankar S.R., Manivasagam T., Krishnamurti A., Ramanathan M. The neuroprotective effect of Withania somnifera root extract in MPTP-intoxicated mice: an analysis of behavioral and biochemical variables. Cell. Mol. Biol. Lett. 2007, 12:473-481. 10.2478/s11658-007-0015-0.
52. Schmidt N., Ferger B. Neurochemical findings in the MPTP model of Parkinson's disease. J. Neural Transm. 2001, 108:1263-1282.
53. Sedelis M., Hofele K., Auburger G.W., Morgan S., Huston J.P., Schwarting R.K. MPTP susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences. Behav. Genet. 2000, 30:171-182.
54. Shobana C., Kumar R.R., Sumathi T. Alcoholic extract of Bacopa monniera Linn. protects against 6-hydroxydopamine-induced changes in behavioral and biochemical aspects: a pilot study. Cell. Mol. Neurobiol. 2012, 32:1099-1112. 10.1007/s10571-012-9833-3.
55. Smeyne M., Smeyne R.J. Glutathione metabolism and Parkinson's disease. Free Radic. Biol. Med. 2013, 62:13-25.
56. Sriram K., Pai K.S., Boyd M.R., Ravindranath V. Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice. Brain Res. 1997, 749:44-52.
57. Subhashree S., Kumaravel M., Syam Praveen Kumar J., Sudha Rani S. In vitro neuroprotective effect of Valeriana wallichii extract against neurotoxin and endoplasmic reticulum stress induced cell death in SH-SY5Y cells. Am. J. Phytomed. Clin. Ther. 2014, 2:509-523.
58. Sudati J.H., Vieira F.A., Pavin S.S., Dias G.R., Seeger R.L., Golombieski R., Athayde M.L., Soares F.A., Rocha J.B., Barbosa N.V. Valeriana officinalis attenuates the rotenone-induced toxicity in Drosophila melanogaster. Neurotoxicology 2013, 37:118-126. 10.1016/j.neuro.2013.04.006.
59. Tamilselvam K., Braidy N., Manivasagam T., Essa M.M., Prasad N.R., Karthikeyan S., Thenmozhi A.J., Selvaraju S., Guillemin G.J. Neuroprotective effects of hesperidin, a plant flavanone, on rotenone-induced oxidative stress and apoptosis in a cellular model for Parkinson's disease. Oxid. Med. Cell. Longev. 2013, 2013:102741. 10.1155/2013/102741.
60. Tatton W.G., Greenwood C.E. Rescue of dying neurons: a new action for deprenyl in MPTP parkinsonism. J. Neurosci. Res. 1991, 30:666-672.
61. Tillerson J.L., Caudle W.M., Reveron M.E., Miller G.W. Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Exp. Neurol. 2002, 178:80-90.
62. Tilleux S., Hermans E. Neuroinflammation and regulation of glial glutamate uptake in neurological disorders. J. Neurosci. Res. 2007, 85:2059-2070.
63. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U. S. A. 1979, 76:4350-4354.
64. Xu J., Li Y., Guo Y., Guo P., Yamakuni T., Ohizumi Y. Isolation, structural elucidation, and neuroprotective effects of iridoids from Valeriana jatamansi. Biosci. Biotechnol. Biochem. 2012, 76:1401-1403.
65. Yadav S.K., Prakash J., Chouhan S., Singh S.P. Mucuna pruriens seed extract reduces oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in paraquat-induced Parkinsonian mouse model. Neurochem. Int. 2013, 62:1039-1047. 10.1016/j.neuint.2013.03.015.
66. Yang M., Crawley J.N. Simple behavioral assessment of mouse olfaction. Curr. Protoc. Neurosci. 2009, Chapter 8, Unit 8.24. 10.1002/0471142301.ns0824s48.
67. Zhao C., Ling Z., Newman M.B., Bhatia A., Carvey P.M. TNF-alpha knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice. Neurobiol. Dis. 2007, 26:36-46.
68. Zuo L., Motherwell M.S. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease. Gene 2013, 532:18-23. 10.1016/j.gene.2013.07.085.